The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity

被引:330
作者
Siegel, RM [1 ]
Chan, FKM [1 ]
Chun, HJ [1 ]
Lenardo, MJ [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/82712
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Originally identified as a cell surface receptor that triggered the death of lymphocytes and tumor cells, it is now recognized that pas (also known as CD95 or Apo-I) has distinct functions in the life and death of different cell types in the immune system, pas signaling may also be involved in T cell costimulation and proliferation. Although pas deficiency in humans and mice predisposes them towards systemic autoimmunity, Fas-FasL interactions can also facilitate organ-specific immunopathology. Proximal signaling by pas and related receptors depends on subunit preassembly, which accounts for the dominant-negative effect of pathogenic receptor mutants and natural splice variants.
引用
收藏
页码:469 / 474
页数:6
相关论文
共 116 条
[81]   Characterization of two receptors for TRAIL [J].
Schneider, P ;
Bodmer, JL ;
Thome, M ;
Hofmann, K ;
Holler, N ;
Tschopp, J .
FEBS LETTERS, 1997, 416 (03) :329-334
[82]   LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing [J].
Screaton, GR ;
Xu, XN ;
Olsen, AL ;
Cowper, AE ;
Tan, RS ;
McMichael, AJ ;
Bell, JI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4615-4619
[83]   Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors [J].
Sheridan, JP ;
Marsters, SA ;
Pitti, RM ;
Gurney, A ;
Skubatch, M ;
Baldwin, D ;
Ramakrishnan, L ;
Gray, CL ;
Baker, K ;
Wood, WI ;
Goddard, AD ;
Godowski, P ;
Ashkenazi, A .
SCIENCE, 1997, 277 (5327) :818-821
[84]   Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations [J].
Siegel, RM ;
Frederiksen, JK ;
Zacharias, DA ;
Chan, FKM ;
Johnson, M ;
Lynch, D ;
Tsien, RY ;
Lenardo, MJ .
SCIENCE, 2000, 288 (5475) :2354-2357
[85]   A NOVEL LYMPHOPROLIFERATIVE AUTOIMMUNE SYNDROME RESEMBLING MURINE LPR/GLD DISEASE [J].
SNELLER, MC ;
STRAUS, SE ;
JAFFE, ES ;
JAFFE, JS ;
FLEISHER, TA ;
STETLERSTEVENSON, M ;
STROBER, W .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :334-341
[86]   Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis [J].
Sneller, MC ;
Wang, J ;
Dale, JK ;
Strober, W ;
Middelton, LA ;
Choi, YN ;
Fleisher, TA ;
Lim, MS ;
Jaffe, ES ;
Puck, JM ;
Lenardo, MJ ;
Straus, SE .
BLOOD, 1997, 89 (04) :1341-1348
[87]   An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome [J].
Straus, SE ;
Sneller, M ;
Lenardo, MJ ;
Puck, JM ;
Strober, W .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (07) :591-601
[88]   Significant role for Fas in the pathogenesis of autoimmune diabetes [J].
Su, X ;
Hu, QL ;
Kristan, JM ;
Costa, C ;
Shen, YM ;
Gero, D ;
Matis, LA ;
Wang, Y .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2523-2532
[89]   MOLECULAR-CLONING AND EXPRESSION OF THE FAS LIGAND, A NOVEL MEMBER OF THE TUMOR-NECROSIS-FACTOR FAMILY [J].
SUDA, T ;
TAKAHASHI, T ;
GOLSTEIN, P ;
NAGATA, S .
CELL, 1993, 75 (06) :1169-1178
[90]   Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis [J].
Suvannavejh, GC ;
Dal Canto, MC ;
Matis, LA ;
Miller, SD .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (02) :223-231